SPARK's High-Impact Value

Our Customers

Building a Better Future for Cancer Research in Space

Pharmaceuticals
1

Gain more predictive preclinical models, to improve decision-making and cuts down costly trial-and-error in drug development.

R&D Teams
2

Rapid research iterations and breakthrough insights without the complexity of managing space missions.

Academia
3

Unprecedented access to space-based cancer research to explore tumor biology in ways not possible on Earth.

Cancer Patients
4

More personalized and effective cancer treatment options identified before therapy begins.

Image
About SPARK

Our hardware is an orbital lab instrument for translational oncology.

SPARK Microgravity GmbH is a Munich, Germany-based startup dedicated to making microgravity research accessible for cancer scientists and pharmaceutical companies worldwide.  SPARK provides a combined software and hardware platform to facilitate cancer experiments in space.

Learn more
Learn more
Icon
Upcoming mission

Q1 2026 Technology Demo

Limited slots on our misison to the ISS.

Learn more
Learn more
Icon
Upcoming mission

Q2 2026 — ISS

Feasibility runs on ISS and live 1g controls.

Learn more
Learn more
Icon
Our services

Using Microgravity Into Medical Discoveries

Using single-agent efficacy screens in microgravity can reveal whether your drug remains potent under more physiologically realistic conditions.

Learn more
Learn more
Icon

Evaluate drug combinations against tumor models in orbit, revealing synergistic effects that might be overlooked in traditional assays.

Learn more
Learn more
Icon

You will discover whether the potency holds up when cancer cells grow as 3D spheroids and possibly enter different stress states. A clear benefit is identifying any need for dose adjustments.

Learn more
Learn more
Icon

Our -omics data packages illuminate the molecular story behind efficacy or failure, which is ultimately why drugs succeed or fail in patients.

Learn more
Learn more
Icon

The phenotypic data from our imaging service will often feel like you’re directly observing a tumor in a patient – just at a microscopic scale.

Learn more
Learn more
Icon

Using single-agent efficacy screens in microgravity can reveal whether your drug remains potent under more physiologically realistic conditions.

Learn more
Learn more
Icon
Icon
Icon

From Brief to Orbit

Our process is built to deliver seamless, end-to-end solutions—from initial planning and engineering to final deployment and post-launch support.

1
1
2
2
3
3
4
4
1

Mission Plan

Outline your research goals and requirements. Our team will translate them into a microgravity experiment plan.

2

Prepare Engineering

We assemble and test your experiment in our hardware, incorporating your samples. All safety and quality checks are handled according to spaceflight standards.

3

Launch

Our hardware is launched to orbit, and the experiment begins. Together we continuously monitors the misison experiment.

4

Insights

After the mission, we deliver a complete orbital dataset along with initial analysis.

Upcoming mission

Q1 2026 Technology Demo

Limited slots on our misison to the ISS.

Learn more
Learn more
Icon
Selected collaborations across space & life sciences
Logo
Logo
Logo
Logo
Logo
Logo
Logo
Ready to experiment oncology and drug development in orbit?

Share your indication, model, readouts, and desired timing. We’ll align you to the next window and a clear plan of work.

Start Your Mission
Start Your Mission
Icon

By submitting, you agree to be contacted about SPARK programs.